[1]	Hyun J, Han J, Lee C, et al. Pathophysiological aspects of alcohol metabolism in the liver[J]. Int J Mol Sci, 2021, 22(11):5717.DOI:10.3390/ijms22115717. Cited in this article [1]

[2]	Seitz HK, Bataller R, Cortez-Pinto H, et al. Alcoholic liver disease[J]. Nat Rev Dis Primers, 2018, 4(1):16.DOI:10.1038/s41572-018-0014-7. Cited in this article [1]

[3]	Wang T, Jia Z, An C, et al. The protective effect of Auricularia cornea var.Li.polysaccharide on alcoholic liver disease and its effect on intestinal microbiota[J]. Molecules, 2023, 28(24):8003.DOI:10.3390/molecules28248003. Cited in this article [1]

[4]	Valous NA, Popp F, Zornig I, et al. Graph machine learning for integrated multi-omics analysis[J]. Br J Cancer, 2024, 131(2):205-211.DOI:10.1038/s41416-024-02706-7. Cited in this article [1]

[5]	Kang M, Ko E, Mersha TB. A roadmap for multi-omics data integration using deep learning[J]. Brief Bioinform, 2022, 23(1):bbab454.DOI:10.1093/bib/bbab454. Cited in this article [1]

[6]	Anstee QM, Daly AK, Day CP. Genetics of alcoholic liver disease[J]. Semin Liver Dis, 2015, 35(4):361-374.DOI:10.1055/s-0035-1567832. Cited in this article [1]

[7]	Arab JP, Addolorato G, Mathurin P, et al. Alcohol-associated liver disease:integrated management with alcohol use disorder[J]. Clin Gastroenterol Hepatol, 2023, 21(8):2124-2134.DOI:10.1016/j.cgh.2023.02.017. Cited in this article [1]

[8]	Tian C, Stokowski RP, Kershenobich D, et al. Variant in PNPLA3 is associated with alcoholic liver disease[J]. Nat Genet, 2010, 42(1):21-23.DOI:10.1038/ng.488. Cited in this article [1]

[9]	Pirazzi C, Valenti L, Motta BM, et al. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells[J]. Hum Mol Genet, 2014, 23(15):4077-4085.DOI:10.1093/hmg/ddu121. Cited in this article [1]

[10]	Pingitore P, Dongiovanni P, Motta BM, et al. PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis[J]. Hum Mol Genet, 2016, 25(23):5212-5222.DOI:10.1093/hmg/ddw341. Cited in this article [1]

[11]	Buch S, Innes H, Lutz PL, et al. Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis:results from a genome-wide case-control study[J]. Gut, 2023, 72(2):381-391.DOI:10.1136/gutjnl-2022-327196. Cited in this article [2]

[12]	Trepo E, Caruso S, Yang J, et al. Common genetic variation in alcohol-related hepatocellular carcinoma:a case-control genome-wide association study[J]. Lancet Oncol, 2022,23(1):161-171.DOI:10.1016/S1470- 2045(21)00603-3. Cited in this article [2]

[13]	Yang J, Trepo E, Nahon P, et al. PNPLA3 and TM6SF2 variants as risk factors of hepatocellular carcinoma across various etiologies and severity of underlying liver diseases[J]. Int J Cancer, 2019, 144(3):533-544.DOI:10.1002/ijc.31910. Cited in this article [1]

[14]	Buch S, Stickel F, Trepo E, et al. A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis[J]. Nat Genet, 2015, 47(12):1443-1448.DOI:10.1038/ng.3417. Cited in this article [1]

[15]	Abul-Husn NS, Cheng X, Li AH, et al. A protein-truncating hsd17b13 variant and protection from chronic liver disease[J]. N Engl J Med, 2018, 378(12):1096-1106.DOI:10.1056/NEJMoa1712191. Cited in this article [1]

[16]	Yang J, Trepo E, Nahon P, et al. A 17-beta-hydroxysteroid dehydrogenase 13 variant protects from hepatocellular carcinoma development in alcoholic liver disease[J]. Hepatology, 2019, 70(1):231-240.DOI:10.1002/hep.30623. Cited in this article [1]

[17]	Stickel F, Lutz P, Buch S, et al. Genetic variation in hsd17b13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers[J]. Hepatology, 2020, 72(1):88-102.DOI:10.1002/hep.30996. Cited in this article [1]

[18]	Innes H, Nischalke HD, Guha IN, et al. The rs429358 locus in apolipoprotein E is associated with hepatocellular carcinoma in patients with cirrhosis[J]. Hepatol Commun, 2022, 6(5):1213-1226.DOI:10.1002/hep4.1886. Cited in this article [1]

[19]	Mohammadi-Shemirani P, Sood T, Pare G. From’omics to multi-omics technologies:the discovery of novel causal mediators[J]. Curr Atheroscler Rep, 2023, 25(2):55-65.DOI:10.1007/s11883-022-01078-8. Cited in this article [1]

[20]	Lteif C, Huang Y, Guerra LA, et al. Using omics to identify novel therapeutic targets in heart failure[J]. Circ Genom Precis Med, 2024, 17(3):e004398.DOI:10.1161/CIRCGEN.123.004398. Cited in this article [2]

[21]	Seth D, Leo MA, McGuinness PH, et al. Gene expression profiling of alcoholic liver disease in the baboon(papio hamadryas) and human liver[J]. Am J Pathol, 2003, 163(6):2303-2317.DOI:10.1016/S0002-9440(10)63587-0. Cited in this article [1]

[22]	Dou X, Feng L, Ying N, et al. RNA sequencing reveals a comprehensive circular RNA expression profile in a mouse model of alcoholic liver disease[J]. Alcohol Clin Exp Res, 2020, 44(2):415-422.DOI:10.1111/acer.14265. Cited in this article [1]

[23]	Massey V, Parrish A, Argemi J, et al. Integrated multiomics reveals glucose use reprogramming and identifies a novel hexokinase in alcoholic hepatitis[J]. Gastroenterology, 2021, 160(5):1725-1740.DOI:10.1053/j.gastro.2020.12.008. Cited in this article [3]

[24]	Baysoy A, Bai Z, Satija R, et al. The technological landscape and applications of single-cell multi-omics[J]. Nat Rev Mol Cell Biol, 2023, 24(10):695-713.DOI:10.1038/s41580-023-00615-w. Cited in this article [1]

[25]	Cao L, Wu D, Qin L, et al. Single-cell RNA transcriptome profiling of liver cells of short-term alcoholic liver injury in mice[J]. Int J Mol Sci, 2023, 24(5):4344.DOI:10.3390/ijms24054344. Cited in this article [1]

[26]	Liu X, Liu ZX, Morgan TR, et al. Single-cell transcriptomics of peripheral blood mononuclear cells indicates impaired immune and inflammatory responses in alcohol-associated hepatitis[J]. Hum Immunol, 2024, 85(1):110735.DOI:10.1016/j.humimm.2023.110735. Cited in this article [1]

[27]	Kim A, Bellar A, McMullen MR, et al. Functionally diverse inflammatory responses in peripheral and liver monocytes in alcohol-associated hepatitis[J]. Hepatol Commun, 2020, 4(10):1459-1476.DOI:10.1002/hep4.1563. Cited in this article [1]

[28]	Ren A, He W, Rao J, et al. Dysregulation of innate cell types in the hepatic immune microenvironment of alcoholic liver cirrhosis[J]. Front Immunol, 2023, 14:1034356.DOI:10.3389/fimmu.2023.1034356. Cited in this article [1]

[29]

Gao C, Wang S, Xie X, et al. Single-cell profiling of intrahepatic immune cells reveals an expansion of tissue-resident cytotoxic CD4(+) T lymphocyte subset associated with pathogenesis of alcoholic-associated liver diseases[J]. Cell Mol Gastroenterol Hepatol, 2024, 19(2):101411.DOI:10.1016/j.jcmgh.2024.101411. Cited in this article [1]

[30]	Niu L, Thiele M, Geyer PE, et al. Noninvasive proteomic biomarkers for alcohol-related liver disease[J]. Nat Med, 2022, 28(6):1277-1287.DOI:10.1038/s41591-022-01850-y. Cited in this article [4]

[31]	Harris PS, Michel CR, Yun Y, et al. Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB(GPNMB) as a novel hepatic and serum biomarker[J]. Alcohol, 2022, 99:35-48.DOI:10.1016/j.alcohol.2021.11.005. Cited in this article [2]

[32]	Kreimeyer H, Gonzalez CG, Fondevila MF, et al. Faecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis[J]. Gut, 2024, 74(1):103-115.DOI:10.1136/gutjnl-2024-332730. Cited in this article [1]

[33]	Hetland LE, Kimer N, Gluud L. Mass spectrometry-based proteomics in alcoholic and non-alcoholic steatohepatitis[J]. J J Gastroenterol Hepatol, 2021, 7(6):1-10.DOI:10.47829/JJGH.2021.7502. Cited in this article [2]

[34]	Perumal SK, Day LZ, Arumugam MK, et al. Lipid droplet-associated proteins in alcohol-associated fatty liver disease:a proteomic approach[J]. Alcohol Clin Exp Res(Hoboken), 2024, 48(11):2010-2021.DOI:10.1111/acer.15446. Cited in this article [1]

[35]	Lee SJ, Lee DE, Kang JH, et al. New potential biomarker proteins for alcoholic liver disease identified by a comparative proteomics approach[J]. J Cell Biochem, 2017, 118(5):1189-1200.DOI:10.1002/jcb.25770. Cited in this article [1]

[36]	Maras JS, Das S, Bhat A, et al. Dysregulated lipid transport proteins correlate with pathogenesis and outcome in severe alcoholic hepatitis[J]. Hepatol Commun, 2019, 3(12):1598-1625.DOI:10.1002/hep4.1438. Cited in this article [2]

[37]	Niu L, Thiele M, Geyer PE, et al. Noninvasive proteomics biomarkers for alcohol-related liver disease[J]. Nat Med, 2022, 28(6):1277-1287.DOI:10.1038/s41591-022-01850-y. Cited in this article [1]

[38]	Zhang L, Zhang L, Hu Q, et al. Establishment and application of a method for screening the therapeutic drugs of ethanol-induced liver injury based on cellular metabonomics[J]. Biomed Chromatogr, 2018, 32(12):e4369.DOI:10.1002/bmc.4369. Cited in this article [1]

[39]	He L, Xu R, Ma X, et al. Multiomics studies on metabolism changes in alcohol-associated liver disease[J]. J Proteome Res, 2024, 23(11):4962-4972.DOI:10.1021/acs.jproteome.4c00451. Cited in this article [3]

[40]	Harada S, Takebayashi T, Kurihara A, et al. Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men[J]. Environ Health Prev Med, 2016, 21(1):18-26.DOI:10.1007/s12199-015-0494-y. Cited in this article [1]

[41]	Gao B, Zhu Y, Gao N, et al. Integrative analysis of metabolome and microbiome in patients with progressive alcohol-associated liver disease[J]. Metabolites, 2021, 11(11):766.DOI:10.3390/metabo11110766. Cited in this article [2]

[42]

Fang H, Zhang AH, Sun H, et al. High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2019, 1109:112-120.DOI:10.1016/j.jchromb.2019.01.017. Cited in this article [2]

[43]	Huang Y, Niu M, Jing J, et al. Metabolomic analysis uncovers energy supply disturbance as an underlying mechanism of the development of alcohol-associated liver cirrhosis[J]. Hepatol Commun, 2021, 5(6):961-975.DOI:10.1002/hep4.1699. Cited in this article [1]

[44]	Iturrospe E, da Silva KM, Robeyns R, et al. Metabolic signature of ethanol-induced hepatotoxicity in heparg cells by liquid chromatography-mass spectrometry-based untargeted metabolomics[J]. J Proteome Res, 2022, 21(4):1153-1166.DOI:10.1021/acs.jproteome.2c00029. Cited in this article [1]

[45]

Iturrospe E, Robeyns R, da Silva KM, et al. Metabolic signature of HepaRG cells exposed to ethanol and tumor necrosis factor alpha to study alcoholic steatohepatitis by LC-MS-based untargeted metabolomics[J]. Arch Toxicol, 2023, 97(5):1335-1353.DOI:10.1007/s00204-023-03470-y. Cited in this article [1]

[46]	Sakallioglu IT, Tripp B, Kubik J, et al. Multiomics approach captures hepatic metabolic network altered by chronic ethanol administration[J]. Biology(Basel), 2022, 12(1):28.DOI:10.3390/biology12010028. Cited in this article [2]

[47]	Gao B, Lang S, Duan Y, et al. Serum and fecal oxylipins in patients with alcohol-related liver disease[J]. Dig Dis Sci, 2019, 64(7):1878-1892.DOI:10.1007/s10620-019-05638-y. Cited in this article [1]

[48]	Gao B, Zeng S, Maccioni L, et al. Lipidomics for the prediction of progressive liver disease in patients with alcohol use disorder[J]. Metabolites, 2022, 12(5):433.DOI:10.3390/metabo12050433. Cited in this article [2]

[49]	Zhang D, Liu Z, Bai F. Roles of gut microbiota in alcoholic liver disease[J]. Int J Gen Med, 2023, 16:163735-163746.DOI:10.2147/IJGM.S420195. Cited in this article [4]

[50]	Kim N, Ma J, Kim W, et al. Genome-resolved metagenomics:a game changer for microbiome medicine[J]. Exp Mol Med, 2024, 56(7):1501-1512.DOI:10.1038/s12276-024-01262-7. Cited in this article [1]

[51]	Ganesan R, Gupta H, Jeong JJ, et al. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease[J]. Hepatol Int, 2024, 18(2):486-499.DOI:10.1007/s12072-023-10518-9. Cited in this article [2]

[52]	Zheng J, Li Z, Xu H. Intestinal microbiotas and alcoholic hepatitis:pathogenesis and therapeutic value[J]. Int J Mol Sci, 2023, 24(19):14809.DOI:10.3390/ijms241914809. Cited in this article [2]

[53]	Hartmann P, Hochrath K, Horvath A, et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice[J]. Hepatology, 2018, 67(6):2150-2166.DOI:10.1002/hep.29676. Cited in this article [1]

[54]	Zhang Y, Li P, Chen B, et al. Therapeutic effects of fecal microbial transplantation on alcoholic liver injury in rat models[J]. Clin Res Hepatol Gastroenterol, 2024, 48(9):102478.DOI:10.1016/j.clinre.2024.102478. Cited in this article [1]

[55]	Liu H, Fan D, Wang J, et al. Lactobacillus rhamnosus NKU FL1-8 isolated from infant feces ameliorates the alcoholic liver damage by regulating the gut microbiota and intestinal barrier in C57BL/6J mice[J]. Nutrients, 2024, 16(13):2139.DOI:10.3390/nu16132139. Cited in this article [1]

[56]	Lv J, Lang G, Wang Q, et al. Lactobacillus helveticus attenuates alcoholic liver injury via regulation of gut microecology in mice[J]. Microb Biotechnol, 2024, 17(10):e70016.DOI:10.1111/1751-7915.70016. Cited in this article [1]

[57]	Dubinkina VB, Tyakht AV, Odintsova VY, et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease[J]. Microbiome, 2017, 5(1):141.DOI:10.1186/s40168-017-0359-2. Cited in this article [1]

[58]	Park IG, Yoon SJ, Won SM, et al. Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease[J]. Sci Rep, 2024, 14(1):16122.DOI:10.1038/s41598-024-60768-2. Cited in this article [1]

[59]	Wang H, Li X, Shi P, et al. Establishment and evaluation of on-chip intestinal barrier biosystems based on microfluidic techniques[J]. Mater Today Bio, 2024, 26:101079.DOI:10.1016/j.mtbio.2024.101079. Cited in this article [1]

[60]	Yan X, Liu X, Wang Y, et al. Multi-omics integration reveals the hepatoprotective mechanisms of ursolic acid intake against chronic alcohol consumption[J]. Eur J Nutr, 2022, 61(1):115-126.DOI:10.1007/s00394-021-02632-x. Cited in this article [1]

[61]	Wang K, Shi J, Gao S, et al. Oyster protein hydrolysates alleviated chronic alcohol-induced liver injury in mice by regulating hepatic lipid metabolism and inflammation response[J]. Food Res Int, 2022, 160:111647.DOI:10.1016/j.foodres.2022.111647. Cited in this article [1]

[62]	Wang X, Liu Q, Zhang B. Leveraging the complementary nature of RNA-Seq and shotgun proteomics data[J]. Proteomics, 2014, 14(23-24):2676-2687.DOI:10.1002/pmic.201400184. Cited in this article [1]

[63]	Listopad S, Magnan C, Day LZ, et al. Identification of integrated proteomics and transcriptomics signature of alcohol-associated liver disease using machine learning[J]. PLoS Digit Health, 2024, 3(2):e0000447.DOI:10.1371/journal.pdig.0000447. Cited in this article [1]

[64]	Xiao C, Jia R, Li XG, et al. Musculus senhousei peptides alleviated alcoholic liver injury via the gut-liver axis[J]. Food Funct, 2024, 15(13):7124-7135.DOI:10.1039/d4fo01070a. Cited in this article [1]

[65]	Gao B, Duan Y, Lang S, et al. Functional microbiomics reveals alterations of the gut microbiome and host co-metabolism in patients with alcoholic hepatitis[J]. Hepatol Commun, 2020, 4(8):1168-1182.DOI:10.1002/hep4.1537. Cited in this article [1]

[66]	Zhu L, Cao F, Hu Z, et al. Cyanidin-3-O-glucoside alleviates alcoholic liver injury via modulating gut microbiota and metabolites in mice[J]. Nutrients, 2024, 16(5):694.DOI:10.3390/nu16050694. Cited in this article [1]

[67]	Wang Y, Zou Z, Wang S, et al. Golden bile powder prevents drunkenness and alcohol-induced liver injury in mice via the gut microbiota and metabolic modulation[J]. Chin Med, 2024, 19(1):39.DOI:10.1186/s13020-024-00912-2. Cited in this article [1]

[68]	Sun Y, Men Q, Ren X, et al. Low molecular fucoidan alleviated alcohol-induced liver injury in BALB/c mice by regulating the gut microbiota-bile acid-liver axis[J]. Int J Biol Macromol, 2024, 282(Pt 3):136930.DOI:10.1016/j.ijbiomac.2024.136930. Cited in this article [1]

[69]	Das S, Ge X, Han H, et al. The integrated “multiomics” landscape at peak injury and resolution from alcohol-associated liver disease[J]. Hepatol Commun, 2022, 6(1):133-160.DOI:10.1002/hep4.1793. Cited in this article [1]

[70]	Shen H, Zhou L, Zhang H, et al. Dietary fiber alleviates alcoholic liver injury via bacteroides acidifaciens and subsequent ammonia detoxification[J]. Cell Host Microbe, 2024, 32(8):1331-1346.DOI:10.1016/j.chom.2024.06.008. Cited in this article [1]